“A World Without CMT”: That’s the CMTA’s vision, and the driving force behind our mission. We are devoted to:
- Supporting the development of new drugs to treat CMT,
- Improving the quality of life for people with CMT, and,
- Ultimately, finding a cure.
Leading us in our mission is the governing CMTA Board of Directors and a STAR Advisory Board comprised of 26 of the world’s foremost CMT research scientists, clinicians and experts in the field of developing pharmacological therapeutics.
The CMTA currently has more than 30,000 patients, families, and supportive friends in its database—along with hundreds of experts in neurology, genetics, orthopedic surgery, physiatry, physical therapy and podiatry—all committed to our vision.
Please explore our website and the pages below to learn more about how our supporters are helping us meet our goals.